I'm a little confused on this announcement if someone could clarify.
Are we still awaiting initial dosing efficacy results post the safety results released from all patients due now Q4 ? this after the self reported improvement announced of one patient?,
or do we need to wait now for the efficacy of MAD at end of the year 2025 ?
thanks
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.010(0.84%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.16 | $44.47K | 37.52K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18253 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 563 | 1 |
View Market Depth
| Last trade - 15.19pm 16/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |